AU2002252774A1 - Novel method for screening bacterial transcription modulators - Google Patents
Novel method for screening bacterial transcription modulatorsInfo
- Publication number
- AU2002252774A1 AU2002252774A1 AU2002252774A AU5277402A AU2002252774A1 AU 2002252774 A1 AU2002252774 A1 AU 2002252774A1 AU 2002252774 A AU2002252774 A AU 2002252774A AU 5277402 A AU5277402 A AU 5277402A AU 2002252774 A1 AU2002252774 A1 AU 2002252774A1
- Authority
- AU
- Australia
- Prior art keywords
- rna polymerase
- protein
- during transcription
- complexing
- intervening during
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000013518 transcription Methods 0.000 title abstract 5
- 230000035897 transcription Effects 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 230000001580 bacterial effect Effects 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 abstract 6
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 abstract 6
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 230000000536 complexating effect Effects 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
A method for detecting a compound modulating complexing between RNA polymerase and a protein intervening during transcription, which consists in: incubating a mixture comprising RNA polymerase intervening during transcription and the compound to be detected; detecting, by a complexing test, the possible significant variation of the amount of complex formed between RNA polymerase and the protein relative to a control value corresponding to the amount of complex formed between RNA polymerase and the protein in the absence of any modulator; and deducing therefrom, when there is a significant variation as defined above, that there has been formation of a bond between the compound and RNA polymerase and/or the protein intervening during transcription, which results in a modulation of the complexing between RNA polymerase and the protein intervening during transcription.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR00/15332 | 2000-11-28 | ||
| FR0015332A FR2817349B1 (en) | 2000-11-28 | 2000-11-28 | NEW METHOD FOR SCREENING MODULATORS OF THE BACTERIAL TRANSCRIPTION |
| PCT/FR2001/003749 WO2002044735A1 (en) | 2000-11-28 | 2001-11-27 | Novel method for screening bacterial transcription modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002252774A1 true AU2002252774A1 (en) | 2002-06-11 |
Family
ID=8856947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002252774A Abandoned AU2002252774A1 (en) | 2000-11-28 | 2001-11-27 | Novel method for screening bacterial transcription modulators |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040048283A1 (en) |
| EP (1) | EP1337857B1 (en) |
| JP (1) | JP2004523218A (en) |
| AT (1) | ATE421090T1 (en) |
| AU (1) | AU2002252774A1 (en) |
| CA (1) | CA2430174A1 (en) |
| DE (1) | DE60137445D1 (en) |
| ES (1) | ES2321482T3 (en) |
| FR (1) | FR2817349B1 (en) |
| WO (1) | WO2002044735A1 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6843043B2 (en) * | 2002-09-13 | 2005-01-18 | Alkar Rapidpak, Inc. | Web packaging pasteurization system |
| WO2006037102A2 (en) * | 2004-09-27 | 2006-04-06 | Epicentre Technologies | Methods for identifying polymerase inhibitors |
| EP2054058B1 (en) * | 2006-08-04 | 2016-11-09 | Beth Israel Deaconess Medical Center | Inhibitors of pyruvate kinase and methods of treating disease |
| CN102448951B (en) | 2009-04-06 | 2017-05-10 | 安吉奥斯医药品有限公司 | Therapeutic compositions and related methods of use |
| EP2427441B1 (en) | 2009-05-04 | 2016-12-14 | Agios Pharmaceuticals, Inc. | Pkm2 activators for use in the treatment of cancer |
| KR100984735B1 (en) * | 2009-05-28 | 2010-10-01 | 동국대학교 산학협력단 | New concept drug developement for screening drug candidate inhibitor of target protein-protein interaction |
| EP2448581B1 (en) | 2009-06-29 | 2016-12-07 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
| KR101850813B1 (en) | 2009-06-29 | 2018-04-20 | 아지오스 파마슈티컬스 아이엔씨. | Therapeutic compounds and compositions |
| EP2651898B1 (en) | 2010-12-17 | 2015-12-09 | Agios Pharmaceuticals, Inc. | Novel n-(4-(azetidine-1-carbonyl)phenyl)-(hetero-)arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators |
| CA2822432C (en) | 2010-12-21 | 2019-09-24 | Agios Pharmaceuticals, Inc. | Bicyclic pkm2 activators |
| TWI549947B (en) | 2010-12-29 | 2016-09-21 | 阿吉歐斯製藥公司 | Therapeutic compounds and compositions |
| ME03074B (en) | 2011-05-03 | 2019-01-20 | Agios Pharmaceuticals Inc | Pyruvate kinase activators for use in therapy |
| JP7320339B2 (en) | 2015-06-11 | 2023-08-03 | アジオス ファーマシューティカルズ， インコーポレイテッド | Methods of using pyruvate kinase activators |
| CN116284442B (en) * | 2023-02-08 | 2023-10-17 | 中国农业科学院生物技术研究所 | Fusion protein for controlling leaf color and application of fusion protein in research on interaction of plant transcription factors and DNA |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5591838A (en) * | 1993-02-12 | 1997-01-07 | Board Of Regents, The University Of Texas System | Detection of conversion to mucoidy in pseudomonas aeruginosa infecting cystic fibrosis patients |
| ATE408621T1 (en) * | 1995-05-30 | 2008-10-15 | Astrazeneca Ab | DNA MOLECULES |
| CA2316769A1 (en) * | 1997-12-23 | 1999-07-01 | Lawrence E. Samelson | The protein tyrosine kinase substrate lat and its use in the identification of (ant)agonists of the kinase |
-
2000
- 2000-11-28 FR FR0015332A patent/FR2817349B1/en not_active Expired - Fee Related
-
2001
- 2001-11-27 DE DE60137445T patent/DE60137445D1/en not_active Expired - Lifetime
- 2001-11-27 JP JP2002546226A patent/JP2004523218A/en active Pending
- 2001-11-27 WO PCT/FR2001/003749 patent/WO2002044735A1/en active Application Filing
- 2001-11-27 AU AU2002252774A patent/AU2002252774A1/en not_active Abandoned
- 2001-11-27 EP EP01998834A patent/EP1337857B1/en not_active Expired - Lifetime
- 2001-11-27 ES ES01998834T patent/ES2321482T3/en not_active Expired - Lifetime
- 2001-11-27 CA CA002430174A patent/CA2430174A1/en not_active Abandoned
- 2001-11-27 AT AT01998834T patent/ATE421090T1/en not_active IP Right Cessation
- 2001-11-27 US US10/432,987 patent/US20040048283A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE421090T1 (en) | 2009-01-15 |
| ES2321482T3 (en) | 2009-06-08 |
| DE60137445D1 (en) | 2009-03-05 |
| US20040048283A1 (en) | 2004-03-11 |
| EP1337857B1 (en) | 2009-01-14 |
| EP1337857A1 (en) | 2003-08-27 |
| FR2817349B1 (en) | 2003-06-20 |
| WO2002044735A1 (en) | 2002-06-06 |
| JP2004523218A (en) | 2004-08-05 |
| FR2817349A1 (en) | 2002-05-31 |
| CA2430174A1 (en) | 2002-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002252774A1 (en) | Novel method for screening bacterial transcription modulators | |
| WO2003014347A3 (en) | Plant seed specific promoters | |
| EP1199371A3 (en) | Methods for identifying products employing reporter gene expression | |
| EP0976829A3 (en) | Protein-deamidating enzyme, gene encoding the same, production process therefor, and use thereof | |
| WO2003050295A3 (en) | Assays and implements for determining and modulating hsp90 binding activity | |
| AU3738597A (en) | Molecular model for vla-4 inhibitors | |
| AU544496B2 (en) | Assay method using enzymes as labelling substances | |
| ATE490332T1 (en) | METHOD FOR PRODUCING VITAMINS | |
| WO2003040323A3 (en) | Bacterial ion channel and a method for screening ion channel modulators | |
| WO2002002811A3 (en) | Method for controlling the microbiological quality of an aqueous medium and kit therefor | |
| AU1811197A (en) | Method for treating biopolymers, microorganisms or materials by using more than one type of magnetic particles | |
| AU1873899A (en) | A method for improved channel impulse response estimation in tdma systems | |
| CA2063822A1 (en) | Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators | |
| WO2000050580A3 (en) | Composition, methods and reagents for the synthesis of a soluble form of human phex | |
| WO2002048838A3 (en) | Business method for a marketing strategy | |
| EP1298205A4 (en) | Novel lipase | |
| AU4247300A (en) | Fta-coated media for use as a molecular diagnostic tool | |
| DE60227335D1 (en) | Continuous process for the modification of starch and starch derivatives by means of branching enzymes | |
| ATE556143T1 (en) | PROCESS FOR CULTIVATION OF MICROORGANISMS OF THE GENUS THRAUSTOCHYTRIEALES | |
| AU2002312899A1 (en) | Hybrid method for the production of carriers for analyte determination | |
| WO2004042352A3 (en) | Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates | |
| AU2003276366A1 (en) | Bacterial test method by glycated label binding | |
| AU2001280446A1 (en) | Limiting the presence of microorganisms using polymer-bound metal-containing compositions | |
| WO2004078783A3 (en) | Enzymes involved in apoptosis | |
| WO2004035801A3 (en) | Enzymatic polymerisation of miniemulsions |